View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2053-09-01 |
| Par Value | |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 940.00 |
| Coupon | 2.77 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 940 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This AMGEN Inc. corporate note has a 2.77% fixed rate coupon paid on a semi-annual basis. It was issued on August 17, 2020 with an issue size of 940.00 million USD and matures on September 01, 2053 with a last coupon date of March 01, 2053. |
Amgen Inc., founded in 1980 and headquartered in Thousand Oaks, California, is a leading global biotechnology company focused on discovering, developing, and delivering innovative human therapeutics. Specializing in treatments for serious illnesses, Amgen's key products include biologic medicines for cancer, kidney disease, and osteoporosis, contributing significantly to the advancement of healthcare.